Medical Device Labeling
& Product Review
Medical device manufacturers marketing devices in the United States must comply with FDA labeling and packaging control requirements under 21 CFR Part 820.120. FDA Registration Assistance provides professional Medical Device Labeling & Product Review services — identifying compliance gaps, reviewing label content and durability, and ensuring your device labels meet all FDA Quality System Regulation (QSR) requirements before market.
What Is FDA Medical Device Labeling Control & Who Must Comply
FDA Medical Device Labeling Control is a mandatory quality system requirement under 21 CFR Part 820.120 for any manufacturer, packer, or distributor of medical devices intended for the U.S. market. The regulation requires manufacturers to establish and maintain written procedures ensuring labels are accurate, properly designed, correctly applied, and consistently controlled throughout manufacturing and distribution. Non-compliant labeling can result in FDA Form 483 observations, warning letters, product recalls, import detention, or enforcement action. FDA Registration Assistance reviews your medical device labels and QSR documentation to identify compliance gaps before FDA inspection.
FDA Registration Assistance reviews your medical device labels and packaging against current FDA labeling requirements — verifying label integrity, UDI compliance, DHR documentation, labeling inspection procedures, and QSR controls. Our specialists identify compliance gaps before FDA review, reducing the risk of enforcement action or market delays for your medical devices.
- Required for all device manufacturers marketing in the U.S.
- Covers label integrity, storage, inspection & operations
- UDI compliance verified under 21 CFR Part 830
- Device History Record (DHR) documentation reviewed
- FDA Registration Assistance manages the full labeling review
Our Medical Device Labeling & Product Review Services
Everything medical device manufacturers need to ensure full FDA labeling compliance — from label content review and UDI verification to QSR documentation assessment and packaging control evaluation, handled end-to-end by experienced FDA regulatory specialists.
Label Content & Integrity Review
FDA Registration Assistance reviews your medical device labels for accuracy and regulatory compliance — verifying that all required information is present and correct, labels remain legible and securely affixed, and label content meets FDA requirements under 21 CFR Part 820.120 and applicable device regulations.
UDI & Regulatory Compliance Check
FDA Registration Assistance verifies that your Unique Device Identifier (UDI) is accurately assigned and correctly applied to your device labels — ensuring compliance with FDA UDI requirements under 21 CFR Part 830 and that all required label elements including expiration dates, lot numbers, and storage instructions are present and accurate.
QSR Documentation Review
FDA Registration Assistance reviews your Device History Record (DHR) documentation, labeling inspection procedures, and labeling storage controls against 21 CFR Part 820.120 requirements — identifying gaps and providing actionable recommendations to bring your QSR documentation into full FDA compliance.
Packaging & Labeling Operations Support
FDA Registration Assistance assesses your labeling operations and packaging control procedures — evaluating label application controls, mix-up prevention measures, and traceability requirements under 21 CFR 820.65 — to ensure your labeling operations meet FDA QSR standards and reduce the risk of FDA inspection findings.
Trusted FDA Medical Device Labeling Review Specialists
Helping foreign and domestic medical device manufacturers ensure full FDA labeling compliance — reviewing labels, UDI requirements, QSR documentation, and packaging controls under 21 CFR Part 820.120.
How Our Medical Device Labeling Review Service Works
A simple four-step process to review your medical device labels and ensure full FDA QSR compliance before market.
Submit Your Labels & Documentation
Provide your device labels, labeling artwork, packaging materials, and relevant QSR documentation. FDA Registration Assistance reviews all submitted materials against FDA labeling requirements and identifies the specific regulatory standards applicable to your device.
Label & QSR Review Conducted
FDA Registration Assistance conducts a thorough review of your label content, UDI compliance, DHR documentation, labeling inspection procedures, and packaging controls — evaluating every element against 21 CFR Part 820.120 and applicable device labeling regulations.
Compliance Report Delivered
FDA Registration Assistance delivers a detailed compliance review report — identifying any labeling gaps, non-conformances, or QSR documentation deficiencies — with clear, actionable recommendations to bring your medical device labels into full FDA compliance.
Compliant & Market Ready
FDA Registration Assistance confirms your device labels and QSR documentation are fully compliant — providing ongoing support for label updates, packaging changes, and QSR procedure revisions to keep your medical devices market-ready and compliant at all times.
Complete FDA Medical Device Compliance Solutions
We offer a full range of FDA medical device compliance services — from establishment registration and device listing to U.S. Agent services, QMS support, and annual renewals.
Medical Device Establishment Registration
Register your foreign or domestic medical device establishment with the FDA — required annually for all device manufacturers and distributors under 21 CFR Part 807.
Medical Device Listing
List your medical devices with the FDA alongside your establishment registration — required for all devices manufactured or distributed for the U.S. market.
Medical Device Labeling & Product Review
Ensure your medical device labels and product documentation meet FDA labeling requirements — reviewed by experienced FDA regulatory specialists.
Medical Device DUNS Request Assistance
Obtain your DUNS Number required for FDA Medical Device Establishment Registration — fast and accurate assistance to keep your registration on track.
Medical Device U.S. Agent Services
Designate FDA Registration Assistance as your official U.S. Agent — legally required for all foreign medical device establishments registering with the FDA.
Medical Device Listing Certificate
Obtain your official FDA Medical Device Listing Certificate confirming your device is registered and listed with the FDA — for clients, distributors, and partners worldwide.
QMS / cGMP Support
Establish and maintain your Quality Management System (QMS) and current Good Manufacturing Practices (cGMP) to meet FDA medical device quality requirements.
Medical Device Annual Establishment Renewal
Ensure your FDA Medical Device Establishment Registration is renewed on time every fiscal year — avoiding compliance gaps, enforcement risk, and marketing disruptions.
Import Alert & Device Detention Resolution
Get expert help resolving FDA medical device import alerts and detention notices — restoring your device's ability to enter U.S. commerce as quickly as possible.
What a Compliant Medical Device Labeler Must Do Under QSR
Under 21 CFR Part 820.120 and related provisions, every manufacturer, packer, repackager, relabeler, or distributor of a U.S.-marketed medical device must meet the following specific labeling responsibilities.
Establish Written Labeling Procedures
Maintain documented SOPs under 21 CFR 820.120 covering label inspection, storage, operations, integrity, and control-number application. Procedures must be approved, implemented, and reviewed under 21 CFR 820.40 document controls.
Inspect Each Label Before Use
Examine every labeling for accuracy — including correct expiration date, control number, storage instructions, and any other applicable information — prior to release. Release must be performed and documented by a designated individual under 21 CFR 820.120(b).
Apply a Compliant UDI on Label & Package
Assign and place a Unique Device Identifier (UDI) — composed of a Device Identifier (DI) and applicable Production Identifier (PI) — on the device label and each level of packaging in both plain-text and Automatic Identification and Data Capture (AIDC) form, as required by 21 CFR 801.40 and 21 CFR Part 830.
Submit & Maintain GUDID Data
Submit Device Identifier records to FDA's Global Unique Device Identification Database (GUDID) and update them within ten business days of any change to brand, model, package configuration, or DI under 21 CFR Part 830.310.
Control Labeling Storage
Store labels and labeling materials in a manner that prevents mix-ups, deterioration, and unauthorized access — including separation of labels for different devices, sizes, or versions — under 21 CFR 820.120(c).
Verify Label Integrity Through Use
Ensure labels remain legible and securely affixed during all expected conditions of processing, storage, handling, distribution, sterilization (where applicable), and use — and demonstrate this through validation testing under 21 CFR 820.120(a).
Document Labeling in the DHR
Record each device's labeling history in the Device History Record under 21 CFR 820.184(d) — including the primary identification label, labels used, control numbers, and any expiration date — to enable traceability and post-market investigation.
Re-Review After Material Changes
Re-evaluate labeling after any change to indications, intended use, ingredients, materials, packaging, sterilization method, UDI, or 510(k) clearance status — and determine whether a new 510(k) is required under 21 CFR 807.81(a)(3) before market.
Medical Device Labeling & Product Review vs 510(k) Premarket Notification
Manufacturers often confuse a Labeling & Product Review with a 510(k) submission because both involve "label review." They are completely separate regulatory activities serving different functions.
| Attribute | Medical Device Labeling & Product Review | 510(k) Premarket Notification |
|---|---|---|
| Who Designates It | The manufacturer — performed in-house or by a regulatory consultant such as FDA Registration Assistance | The manufacturer files; FDA's Center for Devices and Radiological Health (CDRH) reviews and clears it |
| Who/What It Represents | A compliance audit of the device's labels, IFU, packaging, UDI, and QSR documentation | A premarket submission demonstrating substantial equivalence to a legally marketed predicate device |
| Required By | 21 CFR Part 820.120 (QSR Labeling Controls) and ongoing post-market obligations | FD&C Act Section 510(k); 21 CFR Part 807 Subpart E — required before marketing most Class II devices |
| Governing Regulation | 21 CFR Part 820.120, 21 CFR Part 801, 21 CFR Part 830 | 21 CFR Part 807 Subpart E (Premarket Notification Procedures) |
| Primary Function | Verify labeling content, integrity, UDI compliance, and QSR documentation before/after market | Obtain FDA clearance (a "K-number") to legally market a new device based on substantial equivalence |
| Required For | All Class I, II, and III devices marketed in the U.S. — regardless of 510(k) status | Most Class II devices and certain Class I/III devices not otherwise exempt under 21 CFR 807.85 |
A 510(k) Premarket Notification and a Medical Device Labeling & Product Review are different regulatory activities — and most manufacturers need both. A 510(k) is a one-time clearance obtained from FDA before market; a labeling review is an ongoing compliance check performed every time labels, IFU, UDI, or QSR documentation change. Even after a 510(k) is cleared, the manufacturer remains responsible for keeping labels compliant under 21 CFR Part 820.120 throughout the product life cycle. FDA Registration Assistance routinely supports both activities so manufacturers avoid the common mistake of treating 510(k) clearance as the end of labeling obligations.
In-House Labeling Review vs FDA Registration Assistance
Manufacturers can perform a labeling review in-house, but the depth of regulatory expertise, FDA database access, and inspection-readiness differs significantly from a dedicated professional service.
| Attribute | DIY / In-House Review | Recommended FDA Registration Assistance |
|---|---|---|
| Cost | "Free" in cash — but consumes 20–60 hours of internal QA/RA staff time per device review | $249 USD per product review — fixed-fee, no hidden hours |
| Availability | Limited to internal staff working hours; competing priorities; staff turnover causes knowledge loss | Dedicated regulatory specialists available year-round across 135+ countries served |
| Domain-Specific Support | Generic QA knowledge; rarely specialized in current FDA labeling guidance, UDI rules, or GUDID | 15+ years of focused FDA medical device labeling, UDI, GUDID, and QSR expertise |
| Risk of Failure | High — labeling deficiencies are among the most-cited findings in FDA Form 483 device inspections | 100% success rate — reviews completed without post-review compliance issues |
| Confirmation & Handling | Internal checklist; no independent verification; no formal report; gaps often missed until FDA inspection | Written Compliance Review Report, GUDID/AccessGUDID verification, actionable findings, audit trail |
| Renewal & Update Tracking | Manual; depends on staff to flag label/IFU/UDI changes; easy to miss a 510(k)-triggering change | Ongoing support for label updates, GUDID record changes, and 510(k)-trigger analysis |
Most medical device manufacturers choose a dedicated professional service because labeling deficiencies routinely appear in published FDA Warning Letters and Form 483 observations — and the cost of a single warning letter, recall, or import detention dwarfs the price of a $249 expert review. FDA Registration Assistance provides specialized, current FDA-focused expertise that in-house teams typically can't match without dedicated regulatory headcount.
Self-Review (Free) vs Professional Labeling & Product Review
There is no FDA government fee to perform a labeling review yourself — but "free" carries real regulatory risk. Compare the actual trade-offs below.
| Attribute | Self-Review / Friend / Generic Consultant | Recommended FDA Registration Assistance |
|---|---|---|
| Government Fee | $0 — FDA does not charge a fee for a manufacturer to review its own labeling | $0 government fee + $249 professional service fee per product review |
| Pros | No out-of-pocket cost; full control; familiar with the device internally | FDA-current expertise, written report, UDI/GUDID verification, 510(k)-trigger analysis, audit-ready documentation |
| Cons | Easy to miss UDI structure errors, IFU inconsistencies, misbranding under FD&C § 502, and DHR gaps; no independent verification; high re-work risk after FDA findings | Modest fixed cost; requires submitting label artwork and supporting documentation |
| Best For | Very early prototypes that will not yet enter U.S. commerce | Any device about to enter (or already in) U.S. commerce — Class I, II, or III |
The free self-review option costs nothing upfront but routinely costs far more after FDA enforcement. A single Warning Letter, import detention, recall, or marketplace delisting (Amazon, Walmart, Shopify) can cost tens of thousands of dollars and months of lost U.S. market access. A $249 professional review by FDA Registration Assistance removes that risk before the device ships.
Key Medical Device Labeling Terms You Should Know
A working knowledge of these FDA terms helps manufacturers, RA/QA leads, and importers navigate medical device labeling compliance under 21 CFR Parts 801, 820, and 830.
Why Medical Device Labeling Most Often Fails FDA Review
The vast majority of FDA labeling enforcement actions trace back to the same recurring failure modes. Each one is preventable with a structured pre-market review.
Missing or Incorrect UDI
A missing UDI, wrong DI structure, or unregistered GUDID record causes immediate import refusal and FDA Form 483 observations under 21 CFR Part 830.
Label Loses Integrity After Sterilization
Labels that smudge, peel, or fade during EtO, gamma, or steam sterilization violate the label-integrity requirement of 21 CFR 820.120(a) — even if printed content is correct.
IFU Inconsistent With 510(k) Clearance
Indications, warnings, or contraindications in the IFU that differ from the cleared 510(k) Indications for Use statement constitute misbranding under FD&C Act § 502.
Missing Manufacturer Identification
Failure to include the name and place of business of the labeler under 21 CFR 801.1 — or unclear "Manufactured for / Distributed by" attribution — is misbranding under FD&C Act § 502.
No Written Labeling SOPs
The single most-cited 21 CFR 820.120 violation: no written labeling procedures, no documented label inspection, or no labeling release approval. Triggers immediate Form 483 observations.
DHR Missing Labeling Records
Device History Records that lack the labels used, control numbers, or release signatures violate 21 CFR 820.184(d) — and frequently cause batch holds during FDA inspection.
Labeling Mix-Up During Operations
Applying the wrong label, wrong size, or wrong version to a device — typically caused by inadequate label-storage segregation — violates 21 CFR 820.120(d) and is a frequent recall trigger.
GUDID Record Not Updated After Change
Brand-name, model, package configuration, or DI changes not reflected in GUDID within ten business days violate 21 CFR Part 830.310 and trigger Amazon, Walmart, and Shopify listing rejections.
Frequently Asked Questions — Medical Device Labeling & Product Review
Find answers to the most common questions about FDA Medical Device Labeling & Product Review, annual renewal requirements, and how FDA Registration Assistance helps device companies stay compliant.
What regulation governs FDA medical device labeling control?
FDA medical device labeling and packaging controls are governed primarily by 21 CFR Part 820.120 under the FDA Quality System Regulation (QSR). Additional labeling requirements apply under 21 CFR Part 801 (general device labeling), 21 CFR Part 830 (Unique Device Identification), and device-specific regulations in 21 CFR Parts 862–892.
Who must comply with FDA medical device labeling requirements?
Any manufacturer, packer, repackager, relabeler, or distributor of medical devices intended for commercial distribution in the United States must comply with FDA labeling requirements. This includes both domestic and foreign device companies marketing devices in the U.S. market.
What are the five labeling controls required under 21 CFR 820.120?
Under 21 CFR Part 820.120, manufacturers must maintain written procedures for five key labeling controls: (1) Label Integrity — labels must remain legible and securely affixed under normal use conditions; (2) Labeling Inspection — labels must be examined for accuracy before use; (3) Labeling Storage — labels must be stored to prevent mix-ups and damage; (4) Labeling Operations — correct labels must be applied to correct devices; and (5) Control Numbers — traceability labeling required for applicable devices under 21 CFR 820.65.
What is a Unique Device Identifier (UDI) and is it required on labels?
A Unique Device Identifier (UDI) is a unique numeric or alphanumeric code that identifies a medical device and its version or model. UDI labeling is required under 21 CFR Part 830 for most medical devices intended for U.S. commercial distribution. The UDI must appear on the device label and packaging, and device information must be submitted to the FDA's Global Unique Device Identification Database (GUDID). FDA Registration Assistance verifies UDI compliance as part of the labeling review.
What is a Device History Record (DHR) and what labeling documentation is required?
A Device History Record (DHR) is a required production record under 21 CFR Part 820.184 that documents the complete manufacturing history of each device. Labeling documentation required in the DHR includes the date labels were applied, the specific labels used, the quantity of labels issued, and review and approval signatures. FDA Registration Assistance reviews your DHR labeling documentation as part of the QSR compliance review.
What information must appear on a medical device label?
Under 21 CFR Part 801, medical device labels must include the device name, manufacturer name and address, quantity of contents, and any required warnings or directions for use. Additional required elements may include the UDI, expiration date, lot or control number, storage and handling instructions, indications for use, and applicable regulatory statements depending on device classification and intended use. FDA Registration Assistance reviews all label elements for completeness and compliance.
What are the consequences of non-compliant medical device labeling?
Non-compliant medical device labeling can result in FDA Form 483 inspection observations, warning letters, product recalls, import detention or refusal of devices at U.S. ports of entry, seizure of devices, injunctions, and other FDA enforcement actions. Labeling deficiencies are among the most commonly cited issues in FDA device inspections. FDA Registration Assistance identifies labeling compliance gaps before FDA review to reduce these risks.
Does FDA require written labeling procedures under QSR?
Yes. Under 21 CFR Part 820.120, manufacturers must establish and maintain written procedures for all labeling activities — including label inspection, labeling storage, labeling operations, and label integrity controls. These written procedures must be documented, implemented, and maintained as part of the manufacturer's Quality Management System. FDA Registration Assistance reviews existing labeling procedures for QSR compliance.
What is label integrity under FDA labeling regulations?
Label integrity under 21 CFR Part 820.120 requires that medical device labels remain legible and securely affixed to the device or packaging throughout normal storage, handling, shipping, and use conditions. Labels that become unreadable, detach, or are damaged during distribution do not meet FDA requirements — even if the label content itself is compliant. FDA Registration Assistance evaluates label durability and integrity as part of the labeling review.
Can FDA Registration Assistance review labels for foreign device manufacturers?
Yes. FDA Registration Assistance provides medical device labeling review services for both domestic and foreign device manufacturers worldwide. Foreign manufacturers marketing devices in the U.S. must comply with all applicable FDA labeling requirements — including 21 CFR Parts 801, 820.120, and 830. FDA Registration Assistance reviews your labels against current FDA requirements regardless of your country of manufacture.
What is the difference between device labeling and device packaging?
Under FDA regulations, "labeling" includes all labels and other written, printed, or graphic materials on or accompanying a device — including package inserts, instructions for use, and promotional materials. "Packaging" refers to the physical container or wrapper. Under 21 CFR Part 820.120, both labeling and packaging controls must be addressed in written procedures. FDA Registration Assistance reviews both labeling content and packaging control procedures.
Does labeling compliance apply to device Instructions for Use (IFU)?
Yes. Instructions for Use (IFU) are considered part of device labeling under 21 CFR Part 801 and must comply with all applicable labeling requirements. IFUs must accurately describe the device's intended use, contraindications, warnings, precautions, and directions for use. FDA Registration Assistance reviews IFUs and other accompanying documents as part of the medical device labeling review.
How much does a medical device labeling review cost?
FDA Registration Assistance charges $249 per product review for Medical Device Labeling & Product Review services. This covers a full review of your device labels and packaging against applicable FDA labeling requirements, including 21 CFR Parts 801, 820.120, and UDI requirements. Contact FDA Registration Assistance to discuss your specific labeling review needs.
What documents should I provide for a labeling review?
To conduct a thorough labeling review, FDA Registration Assistance typically requires your device label artwork, packaging materials, Instructions for Use (IFU), any existing labeling SOPs or procedures, your device classification and product code, and any relevant Device History Record documentation. Providing complete documentation allows FDA Registration Assistance to conduct a comprehensive compliance assessment.
Can FDA Registration Assistance review labeling before a 510(k) submission?
Yes. FDA Registration Assistance can review your medical device labeling prior to a 510(k) Premarket Notification submission — helping ensure that your proposed labeling is consistent with the device's intended use, indications for use, and contraindications as described in the 510(k). Labeling review prior to submission helps identify issues that could result in FDA requests for additional information or delays in clearance.
Does FDA Registration Assistance assist with the full medical device compliance process?
Yes. FDA Registration Assistance provides comprehensive medical device compliance support — including establishment registration, device listing, labeling and product review, U.S. Agent services, DUNS number assistance, listing certificate issuance, QMS/cGMP support, annual registration renewal, and import alert resolution. Contact us to discuss your full compliance requirements.
What exactly is included in the $249 Medical Device Labeling & Product Review fee?
The $249 per-product review fee covers a complete compliance assessment of one medical device's labels, packaging artwork, and Instructions for Use against 21 CFR Part 801 (general labeling), 21 CFR Part 820.120 (QSR labeling controls), and 21 CFR Part 830 (UDI requirements). Included: verification of required label elements (manufacturer identification, intended use, warnings, lot/control numbers, storage instructions, Rx/OTC statement); UDI DI/PI structure check against GUDID; IFU consistency review against the device's 510(k) Indications for Use (where applicable); DHR labeling documentation review; written labeling SOP gap analysis; and a final written Compliance Review Report with actionable findings. Bundled with Medical Device Establishment Registration and Medical Device Listing, you pay the $249 labeling review fee in addition to the registration and listing fees — covering registration, listing, and the labeling/product review in a single engagement.
Can a friend, in-house staffer, or unrelated party perform the medical device labeling review instead?
Legally yes — practically risky. FDA does not require an external reviewer. Under 21 CFR Part 820.120 the manufacturer is responsible for labeling controls, and a qualified internal employee or any third party can perform the review. The problem is that untrained reviewers routinely miss UDI structure errors, IFU/510(k) inconsistencies, misbranding violations under FD&C Act Section 502, missing DHR labeling records, and outdated GUDID submissions — the same deficiencies that account for the majority of FDA Form 483 labeling observations. A professional review by FDA Registration Assistance applies current FDA guidance, GUDID rules, and inspection-readiness criteria that an untrained reviewer or generic consultant typically does not know.
What happens if FDA identifies non-compliant labeling on my medical device?
FDA can take escalating enforcement action. Common outcomes include FDA Form 483 observations during inspection, an Untitled Letter or Warning Letter posted publicly on FDA.gov, mandatory voluntary recall under 21 CFR Part 7, refusal of admission at U.S. ports under FD&C Act Section 801(a) (import detention), seizure, injunction, and civil money penalties. Marketplaces such as Amazon, Walmart, and Shopify can also delist products tied to a public FDA enforcement record. The faster a manufacturer corrects the labeling and submits a written response, the lower the risk of escalation. FDA Registration Assistance also assists with Import Alert & Device Detention Resolution.
How do I update or change labeling on an existing FDA device listing?
Update the GUDID record and, where applicable, the device listing in FDA's Unified Registration and Listing System (FURLS). Under 21 CFR Part 830.310 the labeler must update the GUDID record within ten business days of changes such as brand name, model, package configuration, or UDI changes. Substantive changes that affect indications, intended use, or technological characteristics may also require a new 510(k) submission under 21 CFR 807.81(a)(3). FDA Registration Assistance reviews the proposed label change, updates the GUDID record, refreshes the device listing in FURLS, and confirms whether a new 510(k) is triggered before the new label enters U.S. commerce.
Does a software-only medical device (Software as a Medical Device / SaMD) need a physical label?
Yes — even pure-software devices must carry FDA-compliant labeling. For Software as a Medical Device (SaMD), labeling appears in the application's About/Help screen, splash screen, in-app user manual, and downloadable electronic IFU. Required elements still apply under 21 CFR Part 801: manufacturer name and address, version/model number, UDI (where required under 21 CFR Part 830), indications for use, warnings, and any required regulatory statements. FDA Registration Assistance reviews SaMD on-screen labeling, electronic IFU (eIFU under 21 CFR 801.109), and app store listings to ensure compliance.
Do I need a UDI on a Class I exempt medical device?
Most Class I devices still require a UDI — but exemptions exist. Under 21 CFR 830.300, Class I devices that are not implantable, life-supporting, or life-sustaining are generally required to carry a UDI on labels and packaging. However, 21 CFR 801.30 grants exceptions and alternatives for certain Class I and unfinished devices, and some Class I devices listed as exempt under 21 CFR 807.85 may also be exempt from UDI labeling. FDA Registration Assistance determines the exact UDI obligation for your specific product code and device class before labels are printed.
Are over-the-counter (OTC) medical devices held to the same FDA labeling rules as prescription devices?
No — OTC and prescription (Rx) medical devices follow different labeling rules. Prescription devices must carry the "Rx only" statement and limit lay-language indications under 21 CFR 801.109. OTC devices must include lay-language Directions for Use and Principal Display Panel content sufficient for the lay user under 21 CFR 801.5 ("adequate directions for use"). Misclassifying an Rx device as OTC — or vice versa — is a misbranding violation under FD&C Act Section 502. FDA Registration Assistance verifies the correct classification, Rx/OTC labeling, and intended user before market launch.
Can I sell my medical device on Amazon or Walmart without FDA-compliant labeling?
No. Amazon, Walmart, eBay, and Shopify all require sellers of regulated medical devices to provide FDA Establishment Registration and Listing numbers and FDA-compliant labeling before publication. Amazon's medical device approval process specifically requests label images, IFU, and 510(k) clearance (where applicable). Non-compliant or misbranded device labels result in ASIN suspension, listing removal, and seller account holds. FDA Registration Assistance prepares labels, IFU, and product documentation that meet both FDA and major marketplace requirements so listings stay live.
Does my contract manufacturer's name or address need to appear on the medical device label?
Not necessarily — but the labeler of record must appear. Under 21 CFR 801.1, the label must identify the manufacturer, packer, or distributor responsible for placing the device into commerce. If a contract manufacturer produces the device for a specification developer, the specification developer's name and address typically appear as the labeler under 21 CFR 801.1(c), provided the labeling clearly indicates the relationship (e.g., "Manufactured for…" or "Distributed by…"). The contract manufacturer is identified internally in the DMR and DHR but not necessarily on the consumer-facing label.
How often should I have my medical device labeling re-reviewed?
Re-review labeling after every material change, and at minimum annually as part of QSR management review. Required triggers include: brand or model name change, package configuration change, UDI change, indications/intended use revision, new warnings or contraindications, regulatory updates (e.g., new FDA guidance or transition to QMSR), and after any 510(k) clearance or De Novo decision. Under 21 CFR 820.20, management review must verify QSR effectiveness — including labeling controls — on a defined cadence. FDA Registration Assistance offers re-review at the same $249-per-product rate.
What is the difference between misbranding and adulteration in medical device labeling?
They are distinct legal violations under the FD&C Act. Misbranding (Section 502) covers labeling defects — false or misleading statements, missing required information, illegible labels, or false indications. Adulteration (Section 501) covers the device itself — manufactured under non-compliant conditions, contaminated, or failing to meet performance specs. A device with a defective label is misbranded; a device manufactured in a non-QSR-compliant facility is adulterated. Both carry the same FDA enforcement consequences (Warning Letters, recalls, import refusal, seizure) and a single device can be both misbranded and adulterated simultaneously.
Can I use electronic Instructions for Use (eIFU) instead of paper IFU on my medical device?
Yes — for many professional-use devices. Under 21 CFR 801.109 and FDA guidance on the Use of Symbols in Labeling and Electronic Labeling (eIFU), prescription devices intended for use by healthcare professionals may provide IFU in electronic form, subject to specific conditions: the device must be intended for professional use, a paper IFU must be available on request at no charge within three business days, the eIFU must be accessible via a publicly available URL, and the label must direct users to the eIFU. OTC devices generally still require physical IFU. FDA Registration Assistance reviews eIFU portals for compliance.
How do I verify my medical device labeling and registration on the FDA public database?
Use three free public FDA databases. (1) FDA's Establishment Registration & Device Listing database (accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm) to confirm establishment registration and listed devices; (2) AccessGUDID (accessgudid.nlm.nih.gov) to verify each UDI/DI submission and confirm public data matches the printed label; (3) the 510(k) Premarket Notification database (accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm) to verify clearance and cleared indications. FDA Registration Assistance verifies all three records as part of every labeling review to confirm public-facing FDA data matches the device label.
If my foreign facility address changes, do I need to update the medical device label?
Yes — and you must also update FDA. Under 21 CFR 801.1, the labeler's name and address must be truthful and current on the device label. Under 21 CFR Part 807, any change to the establishment's name, address, ownership, or operations must be updated in FURLS within 30 days. The corresponding GUDID record must also be updated within ten business days under 21 CFR Part 830.310. Foreign manufacturers must additionally confirm their U.S. Agent designation and DUNS Number remain accurate. FDA Registration Assistance updates all three systems (FURLS, GUDID, U.S. Agent designation) and re-reviews the new label artwork in a single engagement.
Get Your Medical Device Labels Reviewed Today
Submit your facility and device details and FDA Registration Assistance will prepare and submit your complete FDA Medical Device Establishment Registration — ensuring your facility is accurately registered, your devices are properly listed, and your establishment remains compliant each fiscal year.
Thank You for Reaching Out!
We've received your message and will get back to you within 24 hours. If you need immediate assistance, please call us directly.